The Proteomics of Colorectal Cancer: Identification of a Protein Signature Associated with Prognosis

被引:73
|
作者
O'Dwyer, Donna [1 ]
Ralton, Lynda D. [1 ]
O'Shea, Aisling [1 ]
Murray, Graeme I. [1 ]
机构
[1] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland
来源
PLOS ONE | 2011年 / 6卷 / 11期
基金
英国生物技术与生命科学研究理事会;
关键词
POOR-PROGNOSIS; EXPRESSION; MARKERS; BIOMARKERS; THERAPY; HSP60; CYTOCHROME-P450; PREDICTION; ANNEXINS; GROWTH;
D O I
10.1371/journal.pone.0027718
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Colorectal cancer is one of the commonest types of cancer and there is requirement for the identification of prognostic biomarkers. In this study protein expression profiles have been established for colorectal cancer and normal colonic mucosa by proteomics using a combination of two dimensional gel electrophoresis with fresh frozen sections of paired Dukes B colorectal cancer and normal colorectal mucosa (n = 28), gel image analysis and high performance liquid chromatography-tandem mass spectrometry. Hierarchical cluster analysis and principal components analysis showed that the protein expression profiles of colorectal cancer and normal colonic mucosa clustered into distinct patterns of protein expression. Forty-five proteins were identified as showing at least 1.5 times increased expression in colorectal cancer and the identity of these proteins was confirmed by liquid chromatography-tandem mass spectrometry. Fifteen proteins that showed increased expression were validated by immunohistochemistry using a well characterised colorectal cancer tissue microarray containing 515 primary colorectal cancer, 224 lymph node metastasis and 50 normal colonic mucosal samples. The proteins that showed the greatest degree of overexpression in primary colorectal cancer compared with normal colonic mucosa were heat shock protein 60 (p < 0.001), S100A9 (p < 0.001) and translationally controlled tumour protein (p, 0.001). Analysis of proteins individually identified 14-3-3 beta as a prognostic biomarker (chi(2) = 6.218, p = 0.013, HR = 0.639, 95% CL 0.448-0.913). Hierarchical cluster analysis identified distinct phenotypes associated with survival and a two-protein signature consisting of 14-3-3b and aldehyde dehydrogenase 1 was identified as showing prognostic significance (chi(2) = 7.306, p = 0.007, HR = 0.504, 95% CL 0.303-0.838) and that remained independently prognostic (p = 0.01, HR = 0.416, 95% CL 0.208-0.829) in a multivariate model.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] The DCC protein and prognosis in colorectal cancer
    Shibata, D
    Reale, MA
    Lavin, P
    Silverman, M
    Fearon, ER
    Steele, G
    Jessup, JM
    Loda, M
    Summerhayes, IC
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (23): : 1727 - 1732
  • [42] The DCC protein and prognosis in colorectal cancer
    Caca, K
    Zoller, WG
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1997, 35 (09): : 895 - 897
  • [43] Construction of a prognostic signature associated with liver metastases for prognosis and immune response prediction in colorectal cancer
    Liu, Chang
    Lu, Zhihua
    Yan, Jun
    Xue, Dong
    He, Xiaoyu
    Huang, Wenbo
    Sun, Qi
    Zhao, Wei
    Li, Fanni
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [44] Identification of m6A-Related Biomarkers Associated with Prognosis of Colorectal Cancer
    Zhang, Zhiyong
    Zhang, Xin
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [45] Identification of a prognosis-associated signature associated with energy metabolism in triple-negative breast cancer
    Li, Chao
    Li, Xujun
    Li, Guangming
    Sun, Long
    Zhang, Wei
    Jiang, Jing
    Ge, Qidong
    ONCOLOGY REPORTS, 2020, 44 (03) : 819 - 837
  • [46] A WGCNA-based cancer-associated fibroblast risk signature in colorectal cancer for prognosis and immunotherapy response
    Lv, Yiming
    Hu, Jinhui
    Zheng, Wenqian
    Shan, Lina
    Bai, Bingjun
    Zhu, Hongbo
    Dai, Sheng
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (09) : 2256 - +
  • [47] Identification of a glycolysis-associated lncRNA signature to predict survival of patients with colorectal cancer
    Zhu, Gaoceng
    Kang, Yutian
    Luo, Mei
    Ju, Linling
    Sun, Yajun
    Chen, Lin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2025, 18 (03):
  • [48] Identification of colorectal cancer progression-associated intestinal microbiome and predictive signature construction
    Liu, Jungang
    Huang, Xiaoliang
    Chen, Chuanbin
    Wang, Zhen
    Huang, Zigui
    Qin, Mingjian
    He, Fuhai
    Tang, Binzhe
    Long, Chenyan
    Hu, Hong
    Pan, Shuibo
    Wu, Junduan
    Tang, Weizhong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [49] Identification of colorectal cancer progression-associated intestinal microbiome and predictive signature construction
    Jungang Liu
    Xiaoliang Huang
    Chuanbin Chen
    Zhen Wang
    Zigui Huang
    Mingjian Qin
    Fuhai He
    Binzhe Tang
    Chenyan Long
    Hong Hu
    Shuibo Pan
    Junduan Wu
    Weizhong Tang
    Journal of Translational Medicine, 21
  • [50] Identification of an Autophagy-Related Gene Signature for the Prediction of Prognosis in Early-Stage Colorectal Cancer
    Lin, Xu-tao
    Wu, Qiu-ning
    Qin, Si
    Fan, De-jun
    Lv, Min-yi
    Chen, Xi
    Cai, Jia-wei
    Weng, Jing-rong
    Zou, Yi-feng
    Rong, Yu-ming
    Gao, Feng
    FRONTIERS IN GENETICS, 2021, 12